1.Generation of genetic modified pigs devoid of GGTA1 and expressing the human leukocyte antigen-G5.
Xiaoqing ZHOU ; Yu LIU ; Chengcheng TANG ; Lingyin CHENG ; Shuwen ZHENG ; Yuling ZHENG ; Min CHEN ; Huaqiang YANG ; Qingjian ZOU ; Liangxue LAI
Chinese Journal of Biotechnology 2022;38(3):1096-1111
Pigs are considered as ideal donors for xenotransplantation because they have many physiological and anatomical characteristics similar to human beings. However, antibody-mediated immunity, which includes both natural and induced antibody responses, is a major challenge for the success of pig-to-primate xenotransplantation. Various genetic modification methods help to tailor pigs to be appropriate donors for xenotransplantation. In this study, we applied transcription activator-like effector nuclease (TALEN) to knock out the porcine α-1, 3-galactosyltransferase gene GGTA1, which encodes Gal epitopes that induce hyperacute immune rejection in pig-to-human xenotransplantation. Meanwhile, human leukocyte antigen-G5 gene HLA-G5, which acts as an immunosuppressive factor, was co-transfected with TALEN into porcine fetal fibroblasts. The cell colonies of GGTA1 biallelic knockout with positive transgene for HLA-G5 were chosen as nuclear donors to generate genetic modified piglets through a single round of somatic cell nuclear transfer. As a result, we successfully obtained 20 modified piglets that were positive for GGTA1 knockout (GTKO) and half of them expressed the HLA-G5 protein. Gal epitopes on the cell membrane of GTKO/HLA-G5 piglets were completely absent. Western blotting and immunofluorescence showed that HLA-G5 was expressed in the modified piglets. Functionally, the fibroblasts from the GTKO/HLA-G5 piglets showed enhanced resistance to complement-mediated lysis ability compared with those from GTKO-only or wild-type pigs. These results indicate that the GTKO/HLA-G5 pigs could be a valuable donor model to facilitate laboratory studies and clinics for xenotransplantation.
Animals
;
Animals, Genetically Modified
;
Gene Knockout Techniques
;
HLA Antigens
;
Humans
;
Nuclear Transfer Techniques
;
Swine
;
Transplantation, Heterologous
2.Transgenesis for pig models.
Soo Young YUM ; Ki Young YOON ; Choong Il LEE ; Byeong Chun LEE ; Goo JANG
Journal of Veterinary Science 2016;17(3):261-268
Animal models, particularly pigs, have come to play an important role in translational biomedical research. There have been many pig models with genetically modifications via somatic cell nuclear transfer (SCNT). However, because most transgenic pigs have been produced by random integration to date, the necessity for more exact gene-mutated models using recombinase based conditional gene expression like mice has been raised. Currently, advanced genome-editing technologies enable us to generate specific gene-deleted and -inserted pig models. In the future, the development of pig models with gene editing technologies could be a valuable resource for biomedical research.
Animals
;
Gene Expression
;
Gene Transfer Techniques*
;
Mice
;
Models, Animal
;
Recombinases
;
Swine
4.Gene delivery in peritoneal dialysis related peritoneal fibrosis research.
Xie-Jia LI ; Lin SUN ; Li XIAO ; Fu-You LIU
Chinese Medical Journal 2012;125(12):2219-2224
OBJECTIVETo summarize the development of gene delivery vectors in peritoneal fibrosis research and discuss the feasibility and superiority of lentiviral vectors.
DATA SOURCESThe data in this article were collected from PubMed database with relevant English articles published from 1995 to 2011.
STUDY SELECTIONArticles regarding the gene therapy in peritoneal fibrosis research using non-viral vectors, adenoviral vectors, retroviral vectors, and lentiviral vectors were selected. Data were mainly extracted from 60 articles, which are listed in the reference section of this review.
RESULTSNon-viral vector-mediated gene delivery (including naked DNA for ex vivo, oligonucleotides, ultrasound- contrast agent mediated naked gene delivery, etc.) and viral vector-mediated gene delivery (including adenovirus, helper-dependant adenovirus, and retrovirus vectors) have been successfully applied both in the mechanistic investigation and the potential prevention and treatment of peritoneal fibrosis.
CONCLUSIONSPeritoneal fibrosis is a major complication of peritoneal dialysis (PD). Recently, the wide use of the gene delivery technique made it possible to access and further research peritoneal fibrosis. The use of lentiviral vector is expected to be widely used in PD research in the future due to its advantages in gene delivery.
Gene Transfer Techniques ; Genetic Vectors ; administration & dosage ; Humans ; Peritoneal Dialysis ; Peritoneal Fibrosis ; therapy
5.Cell reprogramming: control key genes to obtain needed cells.
Acta Academiae Medicinae Sinicae 2011;33(6):689-695
Cell reprogramming is a progress in which the memory of a mature cell is erased and then the cell develops novel phenotype and function; ultimately, the fate of the cell changes. Cell reprogramming usually occurs at genes expression levels that no genomic DNA sequence change will be involved. By changing the programs of the genetic expressions of cells in terms of space and time, cell reprogramming alters the differentiation of cells and thus produces the required cells. Further research on cells reprogramming will elucidate the mechanisms that govern the cell development, and thus provides more information of the sources of seed cells used for regeneration medicine. More cells differentiated from many terminally differentiated cells will be obtained, which is extremely important for the understanding of molecular differentiation and for the development of cell replacement therapy. This article summarizes the classification, influencing factors, approaches and latest advances of cells reprogramming.
Animals
;
Cell Dedifferentiation
;
genetics
;
Cell Differentiation
;
genetics
;
Cellular Reprogramming
;
Gene Expression
;
Humans
;
Nuclear Transfer Techniques
6.Comparison of commercialization of transgenic crops in China and world-wide.
Chinese Journal of Biotechnology 2008;24(4):541-546
Currently, transgenic crops create huge economic, social and ecological benefits with the development of its commercial production. For China, the speed of development and commercialization of transgenic crops is a strategic issue for the sustainable agriculture development and the international competitiveness of our agricultural products. In this paper, we compared and analyzed the status of commercialization of transgenic crops in China and world-wide.
Agriculture
;
methods
;
trends
;
China
;
Crops, Agricultural
;
genetics
;
Gene Transfer Techniques
;
trends
;
Plants, Genetically Modified
;
genetics
7.Advances in cationic polymers used as nonviral vectors for gene delivery.
Xianyue REN ; Liqun YANG ; Xuan LIANG ; Zhenzhen LIU ; Yubin DENG
Chinese Journal of Biotechnology 2013;29(5):568-577
Gene therapy has been considered as a promising method for treatment of many diseases, such as acquired and genetic diseases. At present, there are two major vehicles for gene delivery including viral vectors and nonviral vectors. Viral vectors appear as high gene transfection efficiency, but some deficiencies such as inflammatory responses, recombination and mutagenesis have limited their use. On account of low pathogenicity, safety and cost-effectiveness, nonviral vectors have been attracted much attention. Cationic polymers are one of the nonviral vectors which have been widely studied. This review focuses on the structure of the cationic polymers and the interaction mechanism between the vector and DNA. We try to provide a framework for the future design and synthesis of nonviral vectors with high transfection efficiency and low toxicity for gene therapy.
Cations
;
chemistry
;
DNA
;
genetics
;
Gene Transfer Techniques
;
Genetic Therapy
;
methods
;
Genetic Vectors
;
genetics
;
Polymers
;
chemistry
8.Genetically Engineered Mouse Models for Drug Development and Preclinical Trials.
Biomolecules & Therapeutics 2014;22(4):267-274
Drug development and preclinical trials are challenging processes and more than 80% to 90% of drug candidates fail to gain approval from the United States Food and Drug Administration. Predictive and efficient tools are required to discover high quality targets and increase the probability of success in the process of new drug development. One such solution to the challenges faced in the development of new drugs and combination therapies is the use of low-cost and experimentally manageable in vivo animal models. Since the 1980's, scientists have been able to genetically modify the mouse genome by removing or replacing a specific gene, which has improved the identification and validation of target genes of interest. Now genetically engineered mouse models (GEMMs) are widely used and have proved to be a powerful tool in drug discovery processes. This review particularly covers recent fascinating technologies for drug discovery and preclinical trials, targeted transgenesis and RNAi mouse, including application and combination of inducible system. Improvements in technologies and the development of new GEMMs are expected to guide future applications of these models to drug discovery and preclinical trials.
Animals
;
Drug Discovery
;
Gene Transfer Techniques
;
Genome
;
Mice*
;
Models, Animal
;
United States Food and Drug Administration
9.Surface modification and DNA-binding assessment of nano-hydroxyapatite.
Xiong-hui WU ; Hong SUN ; Xiao-wei XING ; Li-hua HUANG ; Su-ping HUANG
Journal of Southern Medical University 2010;30(10):2233-2241
OBJECTIVETo evaluate the impact of surface modification on the DNA-binding ability of nano-hydroxyapatite (nHA).
METHODSChemical co-precipitation-hydrothermal synthesis was utilized to prepare the nHA particles, and polyethylenimine (PEI) was used for surface modification of the nHA. Transmission electron microscopic (TEM) observation and zeta potential detection of the nHA were carried out before and after surface modification. The abilities of the nanoparticles, at different pH values and different concentrations, for DNA-binding and DNA protection against nuclease digestion were assessed before and after surface modification by electrophoresis.
RESULTSTEM observation showed a short rod-like morphology of PEI-modified nHA with uniform particle size and good dispersion; the nHA without the modification tended to aggregate with poor dispersion. With a positive zeta potential, the PEI-modified nHA showed an obviously enhanced ability of DNA binding at different pH values and concentrations, with strong capacity to protect the DNA against Dnase I digestion. At the concentration of 250 µg/ml and a pH value of 7.0, the nHA-PEI showed an optimal efficiency of DNA-binding and DNA protection.
CONCLUSIONnHA with surface modification by PEI can serve as an effective vector for DNA binding and transfer.
Amino Acid Motifs ; DNA ; chemistry ; Durapatite ; chemistry ; Gene Transfer Techniques ; Genetic Vectors ; Nanoparticles ; chemistry ; Polyethyleneimine ; chemistry
10.The construction of a human serum albumin small gene.
Hong-mei ZHANG ; Xiao-ling JIANG ; Huo-sheng WANG ; Li-xiong LI ; Liu-mei XU ; Ping LIN ; Mei-zhong LI ; Min WANG ; Bo-ping ZHOU
Chinese Journal of Hepatology 2006;14(6):461-462